Care revenues The acquisition of Care essentially amounts to an IPO for HC as it's a private company to this point.
Can't guess as to how much they bring in with two clinics operating on two continents through tele-health (generally unaffected, if not enhanced, by the Covid crisis). Oncologists don't work cheap. This all goes to revenue, as well as testing, which will actually become the smaller piece of the pie eventually with treatment providing the most revenue. $$$.